Correlation Between Kiniksa Pharmaceuticals and Nuvalent
Can any of the company-specific risk be diversified away by investing in both Kiniksa Pharmaceuticals and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiniksa Pharmaceuticals and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiniksa Pharmaceuticals and Nuvalent, you can compare the effects of market volatilities on Kiniksa Pharmaceuticals and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiniksa Pharmaceuticals with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiniksa Pharmaceuticals and Nuvalent.
Diversification Opportunities for Kiniksa Pharmaceuticals and Nuvalent
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Kiniksa and Nuvalent is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Kiniksa Pharmaceuticals and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Kiniksa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiniksa Pharmaceuticals are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Kiniksa Pharmaceuticals i.e., Kiniksa Pharmaceuticals and Nuvalent go up and down completely randomly.
Pair Corralation between Kiniksa Pharmaceuticals and Nuvalent
Given the investment horizon of 90 days Kiniksa Pharmaceuticals is expected to under-perform the Nuvalent. But the stock apears to be less risky and, when comparing its historical volatility, Kiniksa Pharmaceuticals is 1.41 times less risky than Nuvalent. The stock trades about -0.05 of its potential returns per unit of risk. The Nuvalent is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 7,174 in Nuvalent on November 3, 2024 and sell it today you would earn a total of 1,407 from holding Nuvalent or generate 19.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.2% |
| Values | Daily Returns |
Kiniksa Pharmaceuticals vs. Nuvalent
Performance |
| Timeline |
| Kiniksa Pharmaceuticals |
| Nuvalent |
Kiniksa Pharmaceuticals and Nuvalent Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiniksa Pharmaceuticals and Nuvalent
The main advantage of trading using opposite Kiniksa Pharmaceuticals and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiniksa Pharmaceuticals position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.| Kiniksa Pharmaceuticals vs. Nuvalent | Kiniksa Pharmaceuticals vs. Ventyx Biosciences | Kiniksa Pharmaceuticals vs. Arcellx | Kiniksa Pharmaceuticals vs. Cullinan Oncology LLC |
| Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |